Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
McDonalds Corp.

Start price
Target price
Perf. (%)
€197.85
11.07.21
€225.00
11.07.22
27.85%
12.07.22

Sustainability is important
Differentiated customer and product portfolio
Well known brand
Top 10 in its market
buy
Restaurant Brands Intl Inc.

Start price
Target price
Perf. (%)
€53.96
11.07.21
€80.00
11.07.22
-4.91%
12.07.22

Fair valuation
Differentiated customer and product portfolio
Very small cyclical dependencies
Known brand
buy
Vapiano SE

Start price
Target price
Perf. (%)
€0.31
11.07.21
€0.75
11.07.22
-67.54%
12.07.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Innovative
Some uniques
buy
Northern Data AG

Start price
Target price
Perf. (%)
€77.30
11.07.21
€180.00
11.07.22
26.78%
18.11.21

Could be worthwhile Investment >10% per year
Undervalued
Standard Investments for future growth
Normal challenges to pay loans and raise capital
Tesla Inc

Start price
Target price
Perf. (%)
€183.70
11.07.21
€293.33
11.07.22
26.89%
12.07.22

Capable Management
Known brand
Probably not worthwhile Investment
Little innovation
buy
Celtic

Start price
Target price
Perf. (%)
€1.27
11.07.21
€2.25
11.07.22
0.79%
12.07.22

Strong uniques
Stable Large shareholder and/or long term investor
Well known brand
Significant cyclical dependencies
buy
Potash West Nl

Start price
Target price
Perf. (%)
€0.008
11.07.21
€0.15
11.07.22
-25.00%
12.07.22

Strong uniques
Differentiated customer and product portfolio
Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
Ocugen Inc.

Start price
Target price
Perf. (%)
€6.40
11.07.21
-
11.07.22
-56.90%
12.07.22

Probably not worthwhile Investment
Meta Material Inc.

Start price
Target price
Perf. (%)
€4.20
11.07.21
-
11.07.22
-76.45%
12.07.22

Probably not worthwhile Investment
buy
TAAT Global Alternatives Inc.

Start price
Target price
Perf. (%)
€2.10
11.07.21
€220.00
11.07.22
-57.00%
12.07.22

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
High Investments for future growth
Undervalued
buy
Churchill Capital Corp. Iv

Start price
Target price
Perf. (%)
€24.12
11.07.21
€160.00
11.07.22
8.31%
12.07.22

Could be very worthwhile Investment >20% year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Marin Software

Start price
Target price
Perf. (%)
€15.50
10.07.21
-
10.07.22
-58.71%
26.07.21

Probably not worthwhile Investment
buy
Nse Industries S.A.

Start price
Target price
Perf. (%)
€15.70
10.07.21
€18.00
10.07.22
31.21%
11.07.22

Could be worthwhile Investment >10% per year
buy
Ordina NV

Start price
Target price
Perf. (%)
€4.09
10.07.21
-
10.07.22
15.79%
11.07.22

Could be worthwhile Investment >10% per year
buy
Yara International

Start price
Target price
Perf. (%)
€46.38
10.07.21
-
10.07.22
-14.12%
11.07.22

Could be worthwhile Investment >10% per year
High dividend yield expected
Good rating
Fair valuation
buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€69.00
10.07.21
-
10.07.22
-25.94%
11.07.22

Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
Growths faster than the competition
buy
Aspermont Ltd.

Start price
Target price
Perf. (%)
€0.018
10.07.21
€0.000
10.07.22
-21.35%
02.05.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Fair valuation
positive Cash Flow expected
buy
Agra Ventures Ltd.

Start price
Target price
Perf. (%)
€2.10
10.07.21
-
10.07.22
-96.10%
02.05.22

Could be worthwhile Investment >10% per year
Inovio Pharma

Start price
Target price
Perf. (%)
€6.92
10.07.21
€5.80
10.07.22
-6.86%
27.11.21

Very low/no dividend yield expected
Risky balance sheet
ROE lower than 10% per year
Increased challenges to pay loans and raise capital
Alibaba Health Information Technology Ltd

Start price
Target price
Perf. (%)
€1.71
10.07.21
€0.30
10.07.22
-67.46%
11.06.22

Revenue growth >5% per year expected
Low dividend yield expected
Risky balance sheet
ROE lower than 10% per year
CytoDyn Inc_INT

Start price
Target price
Perf. (%)
€1.28
10.07.21
€0.80
10.07.22
-30.80%
20.12.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Significant cyclical dependencies
Netlist Inc.

Start price
Target price
Perf. (%)
€5.19
10.07.21
-
10.07.22
35.26%
26.07.21

Probably not worthwhile Investment
CareCloud Inc.

Start price
Target price
Perf. (%)
€6.85
10.07.21
€3.20
10.07.22
-46.86%
11.07.22

Growths slower than the competition
Below average Marketposition
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Adler Real Estate AG

Start price
Target price
Perf. (%)
€12.02
10.07.21
€6.00
10.07.22
-39.77%
11.01.22

Low dividend yield expected
negative Cash Flow expected
Few uniques
Dependend from some customers or products
buy
Antelope Enterprise Hldgs Ltd.

Start price
Target price
Perf. (%)
€3.28
10.07.21
€3.00
10.07.22
-26.22%
21.10.21

Could be worthwhile Investment >10% per year
Fair valuation
EBIT decline/stagnation expected
Lower EBIT Margin than peer group